Knowledge of advances in medical management, as well as endovascular versus surgical treatment of peripheral vascular disease, is of paramount importance to the modern interventional cardiologist. Whether treating peripheral arterial disease, venous disease, pulmonary embolism or renal denervation, this track covers the rapidly evolving, minimally invasive endovascular methods that enable the interventional cardiologist to deliver comprehensive cardiovascular management of patients for preservation of limb and life.
This track has been designed to appeal to both early-career physicians and trainees as well as experienced practitioners. It includes:
- Expert reviews of endovascular techniques
- Coverage of new data and guidelines
- Emerging techniques and devices
- Expert-led live case dealing with different pathology and challenges
All of which it is critical to be familiar with irrespective of your experience and level of training.
After attending SCAI 2021, the learner will be able to:
- Implement optimal strategies for the treatment of SFA Popliteal disease, including the use of drug-eluting/covered technologies, scaffolds, debulking strategies along with appropriateness/cost-effectiveness
- Identify the disparities in care with respect to critical limb ischemia (CLI/CLTI) and how to better address these in a multidisciplinary approach thus optimizing outcomes and enhancing patient care
- Describe the various treatment strategies that exist for patients that present with venothromboembolic disease and how best to manage these patients in a comprehensive Pulmonary Embolism Response Team (PERT) fashion
The topics covered in this track have been chosen to enable you to stay contemporary with interventional practice and improve patient outcomes: whether it is how you address a complex procedure; incorporate a new way to use equipment currently available in your lab; or learning about a new treatment in the pipeline,